<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33765941</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria.</ArticleTitle><Pagination><StartPage>304</StartPage><MedlinePgn>304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-020-05716-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease once thought to be a respiratory infection is now recognised as a multi-system disease affecting the respiratory, cardiovascular, gastrointestinal, neurological, immune, and hematopoietic systems. An emerging body of evidence suggests the persistence of COVID-19 symptoms of varying patterns among some survivors. This study aimed to describe persistent symptoms in COVID-19 survivors and investigate possible risk factors for these persistent symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study used a retrospective study design. The study population comprised of discharged COVID-19 patients. Demographic information, days since discharge, comorbidities, and persistent COVID-19 like symptoms were assessed in patients attending the COVID-19 outpatient clinic in Lagos State. Statistical analysis was done using STATA 15.0 software (StataCorp Texas) with significance placed at p-value &lt;&#x2009;0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 274 patients were enrolled in the study. A majority were within the age group &gt;&#x2009;35 to &#x2264;49&#x2009;years (38.3%), and male (66.1%). More than one-third (40.9%) had persistent COVID-19 symptoms after discharge, and 19.7% had more than three persistent COVID-like symptoms. The most persistent COVID-like symptoms experienced were easy fatigability (12.8%), headaches (12.8%), and chest pain (9.8%). Symptomatic COVID-19 disease with moderate severity compared to mild severity was a predictor of persistent COVID-like symptoms after discharge (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Findings from this study suggests that patients who recovered from COVID-19 disease may still experience COVID-19 like symptoms, particularly fatigue and headaches. Therefore, careful monitoring should be in place after discharge to help mitigate the effects of these symptoms and improve the quality of life of COVID-19 survivors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Osikomaiya</LastName><ForeName>Bodunrin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Lagos Blood Transfusion Services, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erinoso</LastName><ForeName>Olufemi</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0733-3847</Identifier><AffiliationInfo><Affiliation>Lagos State University Teaching Hospital, Lagos, Lagos State, Nigeria. Olufemierinoso@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Kikelomo Ololade</ForeName><Initials>KO</Initials><AffiliationInfo><Affiliation>Lagos State University Teaching Hospital, Lagos, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odusola</LastName><ForeName>Aina Olufemi</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Lagos State University Teaching Hospital, Lagos, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Babafemi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Health Service Commission, Lagos, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyemi</LastName><ForeName>Oluwatosin</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Lagos State University Teaching Hospital, Lagos, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowale</LastName><ForeName>Abimbola</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mainland Hospital, Yaba, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adejumo</LastName><ForeName>Olusola</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Mainland Hospital, Yaba, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falana</LastName><ForeName>Ayodeji</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mainland Hospital, Yaba, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdus-Salam</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Lagos State Ministry of Health, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogboye</LastName><ForeName>Olusegun</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Lagos State Ministry of Health, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osibogun</LastName><ForeName>Akin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Lagos, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abayomi</LastName><ForeName>Akin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lagos State Ministry of Health, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NA</GrantID><Agency>Lagos State Government</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Persistent symptoms</Keyword><Keyword MajorTopicYN="N">Survivors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33765941</ArticleId><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="doi">10.1186/s12879-020-05716-x</ArticleId><ArticleId IdType="pii">10.1186/s12879-020-05716-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available at: https://coronavirus.jhu.edu/map.html Accessed 30 July 2020.</Citation></Reference><Reference><Citation>Nigeria Center for Disease Control. Available at: http://covid19.ncdc.gov.ng/ Last updated July 30th 2020. Accessed 30 July 2020.</Citation></Reference><Reference><Citation>Escand&#xf3;n K, Rasmussen AL, Bogoch I, Murray EJ, Escand&#xf3;n K, Kindrachuk J. COVID-19 and false dichotomies &#x2014; A nuanced review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, masks, and reinfection. OSF Preprints. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314268</ArticleId><ArticleId IdType="pubmed">34315427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862. doi: 10.1136/bmj.m3862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3862</ArticleId><ArticleId IdType="pubmed">33097561</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765. doi: 10.1371/journal.pone.0234765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234765</ArticleId><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Abayomi A, Odukoya O, Osibogun A, Wright O, Adebayo B, Balogun M, et al. Presenting symptoms and predictors of poor outcomes among 2,184 patients with COVID-19 in Lagos state. Int J Infect Dis. 2020;102:226&#x2013;232. doi: 10.1016/j.ijid.2020.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.024</ArticleId><ArticleId IdType="pmc">PMC7566672</ArticleId><ArticleId IdType="pubmed">33075534</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowale A, Abayomi A, Idris J, Omilabu S, Abdus-Salam I, Adebayo B, et al. Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria. Pan Afr Med J. 2020;35(2):24. doi: 10.11604/pamj.supp.2020.35.2.23262.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.supp.2020.35.2.23262</ArticleId><ArticleId IdType="pmc">PMC7875732</ArticleId><ArticleId IdType="pubmed">33623549</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings, and complications of COVID-19. Am J Hematol. 2020;95:834&#x2013;847. doi: 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus&#x2013;Infected Pneumonia. N Engl J Med. 2020;382(13):1199&#x2013;1207. doi: 10.1056/NEJMoa2001316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001316</ArticleId><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. For the Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files CD, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, march&#x2013;June 2020. Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>How long does COVID last? COVID symptom study. Available at: https://covid.joinzoe.com/post/covid-long-term. Accessed 8 Aug 2020.</Citation></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, de Truchis P. Post&#x2013;COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26(11):1448&#x2013;1449. doi: 10.1016/j.cmi.2020.07.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2020:1&#x2013;10. 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P, Arora U, Kumar A, Wig N. The "post-COVID" syndrome: how deep is the damage? J Med Virol. 2020:1&#x2013;2. 10.1002/jmv.26465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. Clinical management of COVID-19 interim guidance. COVID-19: Clinical care. [Published online May 27th 2020]. Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19 Accessed 3 Nov 2020.</Citation></Reference><Reference><Citation>Cai X, Hu X, Otte EI, Wang J, An Y, Li Z, et al. Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am J Geriatr Psychiatry. 2020;28(10):1030&#x2013;1039. doi: 10.1016/j.jagp.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennaro Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp HI, Corner E, Colvin LA. Chronic pain following COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125(4):436&#x2013;440. doi: 10.1016/j.bja.2020.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Olufadewa II, Adesina MA, Oladokun B, Baru A, Oladele RI, TO I, et al. &#x201c;I Was Scared I Might Die Alone&#x201d;: A Qualitative Study on the Physiological and Psychological Experience of COVID-19 Survivors and the Quality of Care Received at Health Facilities. Int J Travel Med Glob Health. 2020;8(2):51&#x2013;57. doi: 10.34172/ijtmgh.2020.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ijtmgh.2020.09</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehy LM. Considerations for Postacute rehabilitation for survivors of COVID-19. JMIR Public Health Surveill. 2020;6(2):e19462. doi: 10.2196/19462.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19462</ArticleId><ArticleId IdType="pmc">PMC7212817</ArticleId><ArticleId IdType="pubmed">32369030</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellhorn P, Klingel K, Burgstahler C. Return to sports after COVID-19 infection. Eur Heart J. 2020:ehaa448. 10.1093/eurheartj/ehaa448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314071</ArticleId><ArticleId IdType="pubmed">32432700</ArticleId></ArticleIdList></Reference><Reference><Citation>Korupolu R, Francisco GE, Levin H, Needham DM. Rehabilitation of critically ill COVID-19 survivors. J Int Soc Phys Rehabil Med. 2020;3(2):45. doi: 10.4103/jisprm.jisprm_8_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jisprm.jisprm_8_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf#:~:text=Using%20available%20preliminary%20data%2C,severe%20or%20critical%20disease. Accessed 19 Oct 2020.</Citation></Reference><Reference><Citation>Kuppalli K, Rasmussen AL. A glimpse into the eye of the COVID-19 cytokine storm. EBioMedicine. 2020;55:102789. doi: 10.1016/j.ebiom.2020.102789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102789</ArticleId><ArticleId IdType="pmc">PMC7204696</ArticleId><ArticleId IdType="pubmed">32388462</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473&#x2013;474. doi: 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, et al. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging. 2020. 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J Eur Heart J. 2020;41:3038&#x2013;3044. doi: 10.1093/eurheartj/ehaa623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa623</ArticleId><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Temgoua MN, Endomba FT, Nkeck JR, Kenfack GU, Tochie JN, Essouma M. Coronavirus disease 2019 (COVID-19) as a multi-systemic disease and its impact in low- and middle-income countries (LMICs) SN Compr Clin Med. 2020;2:1377&#x2013;1387. doi: 10.1007/s42399-020-00417-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00417-7</ArticleId><ArticleId IdType="pmc">PMC7371790</ArticleId><ArticleId IdType="pubmed">32838173</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigeria Centre for Disease Control. National Interim Guidelines for Clinical Management of COVID-19. [Published online March 14th 2020]. Available from: https://reliefweb.int/report/nigeria/national-interim-guidelines-clinical-management-covid-19 Accessed 6 July 2020.</Citation></Reference><Reference><Citation>Mahase E. Covid-19:what do we know about "longcovid"? BMJ. 2020;370:m2815. doi: 10.1136/bmj.m2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>